Nation | Business

Johnson & Johnson Settles Marketing Charges

NPR | Nov. 5, 2013 2:08 a.m. | Updated: Nov. 5, 2013 9 a.m.

Contributed By:

Yuki Noguchi

Johnson & Johnson became the latest drugmaker to reach a costly agreement with the federal government over charges of improper marketing. The widely anticipated settlement, unveiled Monday, covers Natrecor, a drug for congestive heart failure, and antipsychotics Risperdal and Invega.

Comments

blog comments powered by Disqus
Follow on Facebook:
Thanks to our Sponsors:
become a sponsor
Thanks to our Sponsors
become a sponsor